CNLM
CB PHARMA ACQUISISTION CORP SHS (CYM)
CNLM
CNLM
Delisted
CNLM was delisted on the 8th of June, 2016.
8 hedge funds and large institutions have $18.4M invested in CB PHARMA ACQUISISTION CORP SHS (CYM) in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
DKCM
Davidson Kempner Capital Management
New York
|
$3.54M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
$3K |
Top Sellers
| 1 |
GCL
Glazer Capital LLC
New York
|
$0 |
| 2 |
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PAMP
1
Polar Asset Management Partners
Toronto,
Ontario, Canada
| $5.56M | – | – | – |
|
|
WAM
2
Weiss Asset Management
Boston,
Massachusetts
| $4.28M | – | – | – |
|
|
AA
3
AQR Arbitrage
Greenwich,
Connecticut
| $3.54M | – | – | – |
|
|
DKCM
4
Davidson Kempner Capital Management
New York
| $3.54M | +$3.54M | +350,000 | New |
|
|
KIM
5
Karpus Investment Management
Pittsford,
New York
| $1.33M | – | – | – |
|
|
YCM
6
Yakira Capital Management
Westport,
Connecticut
| $126K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $3K | +$990 | +100 | +49% |
|
|
GCL
8
Glazer Capital LLC
New York
| – | -$224K | -21,824 | Closed |
|
|
9
UBS Group
Zurich,
Switzerland
| – | -$12K | -1,233 | Closed |
|